Cancer and inflammatory disease
- Robin Plevin Kathryn McIntosh
Development of novel Inhibitors of CXCL12 production as new medicines for cancer and inflammation. - Martin Wiese Craig Roberts
Flagellum length regulation in Leishmania - Martin Wiese Craig Roberts
Protein kinases as drug target against the infectious disease Human Leishmaniasis - Zahra Rattray Nik Rattray
Targeting the Nuclear Import Pathway as a Treatment for Triple Negative Breast Cancer
Cardiovascular and metabolic disease
- Catherine Lawrence not found cdes10
Anti-parasitical drug targeting and validation - Dino Rotondo
Control of Human Inflammatory Responses and Cell Pathology mechanisms by Prostanoid and endocannabinoid receptors - Gwyn Gould Margaret Cunningham
Extracellular Vesicles and Metabolic Disease - Susan Currie Margaret Cunningham
Investigating anti-cancer drug induced cardiotoxicity in different cell types of the heart - Gwyn Gould Luke Chamberlain
Proximity Labelling proteins near glucose transporters - Susan Currie Gwyn Gould
Regulation of cellular coupling in the healthy and diseased heart - Catherine Lawrence Hui-Rong Jiang
Role of mast cells in the development of obesity and diabetes - Catherine Lawrence not found cdes10
Role of the microbiome in gastrointestinal nematode induced enteropathy.
Drug Discovery, Formulation and Delivery
- Philipp Seib
Biomedical use of Silk - Yvonne Perrie Zahra Rattray
Continuous manufacturing of liposome formulations incorporating anti-cancer agents: Exploiting novel methods in microfluidics. - not found cdes10 Maclean
Development of a light treatment device for cutaneous leishmaniasis - not found cdes10 Alexander Mullen
Development of a novel drug formulation for the treatment of lung cancer. - not found cdes10 Martin Wiese
Development of a vaccine against leishmaniasis. - Christine Dufès
Development of novel tumour-targeted nanomedicines for cancer therapy - Veronique Seidel
Extraction, purification and characterisation of bioactive products from natural sources - Luis Bimbo Gavin Halbert
Formulation of biologics as dry powders for inhalation - RuAngelie Edrada-Ebel
Metabolomics-guided study of antibiotic compounds from marine microbial symbionts and terrestrial endophytes - Zahra Rattray Daniel Markl
Multiscale characterization of particle dissolution - Vania Moreira
Next generation wound dressings - Alexander Mullen Zahra Rattray
The development of oxytocin vaginal formulations for the prevention of postpartum haemorrhage - not found cdes10 Crawford Revie
The use of machine learning in diagnosis of visceral leishmaniasis.
Materials & Manufacture
- Geoffrey Coxon Joop Ter Horst
Advances in medicine development using decracemisation by crystallisation to give single enantiomer drug molecules - facilitating the drug pipeline and production - Iain Oswald
Effect of hydrostatic and non-hydrostatic compression on pharmaceutical materials - Iain Oswald
Multicomponent materials under extreme conditions - Daniel Markl Zahra Rattray
Multimodal in-situ monitoring and modelling of particle dissolution
Microbiology and industrial biotechnology
- Paul Herron
Characterisation of novel streptomycete telomeric proteins - Katherine Duncan
Comparative metabolomics of phylogenetically diverse actinomycetes - Leighton Pritchard Paul Hoskisson
Comprehensive taxonomy, pangenomics and metabolic modelling of Streptomyces. - Paul Hoskisson Arnaud Javelle
Disarm and disengage: repurposing old drugs for bad bugs - Nicholas Tucker
DNA-Binding Antibiotics - Targeting multidrug resistant bacteria. - Arnaud Javelle Paul Hoskisson
Is there a universal mechanism for biological ammonium transport?
Neuroscience and mental health
- Hui-Rong Jiang Shuzo Sakata
Developing novel treatment for Alzheimer’s disease through understanding the disease immunopathogenesis - Trevor Bushell Gwyn Gould
Does mitogen-activated protein kinase phosphatases (MKP-2) play a critical role in regulating neurotransmitter release and synaptic transmission? - Trevor Bushell Hui-Rong Jiang
Does proteinase-activated receptor 2 (PAR2) activation play a key role in depression? - Luke Chamberlain Gwyn Gould
Growth factor mediated trafficking of the tumour suppressor Sprouty-2 - Ben Pickard
Identifying genetic factors that protect against neurofibrillary tangles pathologies in Alzheimer’s disease - Trevor Bushell Shuzo Sakata
Is PAR2 activation neuroprotective in a mouse model of Alzheimer’s Disease? - Charles Kennedy Margaret Cunningham
Novel GPCR interactions as a target for developing new analgesics to treat chronic pain - Shuzo Sakata
State-dependent and cell-type-specific auditory cortical processing on multiple timescales - Hui-Rong Jiang Trevor Bushell
Understanding the role of specific immune molecules in the development of multiple sclerosis